SHL Telemedicine Ltd PGIM US Large-Cap Buffer 12 ETF - November (BATS: NOVP)

Latest news for SHL Telemedicine Ltd PGIM US Large-Cap Buffer 12 ETF - November (BATS:NOVP)

The Fund will invest at least 80% of its net assets (plus any borrowings for investment purposes) in investments that provide exposure to equity securities issued by large-capitalization U.S. companies. The Fund is an actively managed exchange-traded fund (ETF). The Fund considers large-capitalization companies to be companies in which the Underlying ETF (as defined below) invests and/or which are included in the S&P 500 Index.The Fund will invest substantially all of its assets in customized equity or index option contracts known as FLexible EXchange Options (FLEX Options) on the SPDR S&P 500 ETF Trust (the Underlying ETF). FLEX Options trade on an exchange, but provide investors with the ability to customize key contract terms like expiration date, option type (put or call), exercise style, strike price, premium, trading hours and exercise settlement, among others.

PGIM US Large-Cap Buffer 12 ETF - November

SHL Telemedicine Ltd PGIM US Large-Cap Buffer 12 ETF - November

LTC Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LTC#NYSE">LTC</a>) reported quarterly earnings of $0.65 per share which missed the analyst consensus estimate of $0.66 by 1.52 percent. The company reported quarterly sales of $50.116 million which beat the analyst consensus estimate of $49.275 million by 1.71 percent. This is a 3.88 percent increase over sales of $48.246 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

News

LTC Properties Q2 2024 FFO $0.65 Misses $0.66 Estimate, Sales $50.116M Beat $49.275M Estimate

Exclusivity period for Heads of Agreement extended to 31 August 2024
Extension to enable Tembo to consummate material transaction and update disclosure
LONDON, July 29, 2024 (GLOBE NEWSWIRE) -- The Nasdaq-listed B Corp, VivoPower International PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VVPR#NASDAQ">VVPR</a>, "VivoPower")))), announced today that its electric vehicle subsidiary, Tembo e-LV B.V. ("Tembo"), has agreed to a further one month extension of its exclusive heads of agreement with Nasdaq-listed Cactus Acquisition Corporation I (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCTS#NASDAQ">CCTS</a>, CCTSW, CCTSU, "CCTS")))) to 31 August 2024.
The extension is intended to provide additional time for Tembo to consummate a material transaction and update disclosures before finalising a definitive business combination agreement relating to the proposed transaction as well as the independent fairness opinion.

CCTS

VVPR

VivoPower's Tembo Extends Heads Of Agreement Exclusivity For $838M Merger With Cactus Acquisition Corporation I

Equity Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQR#NYSE">EQR</a>) reported quarterly earnings of $0.97 per share which beat the analyst consensus estimate of $0.96 by 1.04 percent. The company reported quarterly sales of $734.163 million which missed the analyst consensus estimate of $734.368 million by 0.03 percent. This is a 2.35 percent increase over sales of $717.309 million the same period last year.

Equity Residential Q2 2024 FFO $0.97 Beats $0.96 Estimate, Rental Income $734.163M Miss $734.368M Estimate

Crane Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) reported quarterly earnings of $1.30 per share which beat the analyst consensus estimate of $1.04 by 25 percent. This is a 18.18 percent increase over earnings of $1.10 per share from the same period last year. The company reported quarterly sales of $581.200 million which beat the analyst consensus estimate of $367.160 million by 58.30 percent. This is a 14.05 percent increase over sales of $509.600 million the same period last year.

Crane Holdings Q2 2024 Adj. EPS $1.30 Beats $1.04 Estimate, Sales $581.200M Beat $367.160M Estimate

Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) has outperformed the market over the past 20 years by 2.74% on an annualized basis producing an average annual return of 11.15%. Currently, Nike has a market capitalization of $110.17 billion. 
Buying $1000 In NKE: If an investor had bought $1000 of NKE stock 20 years ago, it would be worth $8,049.25 today based on a price of $73.48 for NKE at the time of writing.
<h3>Nike's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1722285137_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In Nike 20 Years Ago Would Be Worth This Much Today

IMNM

IMNN

CORRECTION: Imunon Ticker Is "IMNN"

According to the terms of the merger agreement, shareholders of The First will receive 1.00 share of Renasant common stock for each share of The First common stock. Additionally, all options of The First will be cashed out at their in-the-money value at closing. Based on Renasant's closing stock price of $37.09 per share as of July 26, 2024, the implied transaction value is approximately $37.09 per The First share, or $1.2 billion, in the aggregate. Excluding one-time transaction costs, the merger is expected to be immediately accretive to Renasant's estimated earnings per share and to have a positive long-term impact on Renasant's key profitability and operating ratios.
 &nbsp;

FBMS

RNST

Renasant Corporation To Acquire The First Bancshares, Inc. In All-Stock Transaction Valued At ~$1.2B; Shareholders Of The First Will Receive 1 Renasant Common share For Each Share Of The First Common Stock

NovaBay Pharmaceuticals Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBY#NYSE">NBY</a>) shares are lower by 66% to $0.67 over the trailing five sessions after announcing the pricing of its <a href="https://www.benzinga.com/pressreleases/24/07/b39982871/novabay-pharmaceuticals-announces-pricing-of-3-5-million-underwritten-public-offering">public offering</a> of 3.2 million shares (or pre-funded warrants) and Series F-1, F-2, and F-3 warrants.
Each share (or pre-funded warrant) and associated warrants are priced at $1.10. The Series F-1 warrants expire in five years, the F-2 in six months and the F-3 in one year, all with a $1.10 exercise price.
Ladenburg Thalmann &amp; Co. Inc., the underwriter, has a 45-day option to purchase an additional 477,272 shares and/or warrants for over-allotments. Expected gross proceeds are $3.5 million, or $4.0 million if the over-allotment option is fully exercised, before expenses. 
NovaBay plans to use the funds to redeem outstanding debentures and for general corporate purposes. The offering is expected to close around July 29.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/40015199/oil-prices-remain-under-pressure-despite-rising-middle-east-tensions-a-bearish-tria">Oil Prices Remain Under Pressure Despite Rising Middle East Tensions: Analyst Says Bearish Price Trend On Horizon</a>
<h1 class="wp-block-heading">Is NBY A Good Stock To Buy?</h1>
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages — like <a href="https://www.benzinga.com/quote/NBY">NovaBay Pharmaceuticals</a>&#8216;s page for example — there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
These are known as capital allocation programs. NovaBay Pharmaceuticals does not pay a dividend, but obviously there are a few ways it can return value to shareholders. Feel free to search Benzinga's <a href="https://www.benzinga.com/calendars/dividends">dividend calendar</a> for the next company due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
For example, if you're looking to earn an annualized return of 9.16%, you'll need to buy a share of Allspring Inc Opps by Aug. 12, 2024. Once done, you can expect to receive a nominal payout of $0.05 on Sep. 3.
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. 
Looking through the latest news on <a href="https://www.benzinga.com/quote/NBY">NovaBay Pharmaceuticals</a> will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, NBY has a 52-week high of $44.80 and a 52-week low of $0.64.
Read Next: • <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/40016926/markets-brace-for-crucial-interest-rate-shake-up-what-to-expect-from-federal-reserv">Markets Brace For Crucial Interest Rate Shake-Up: What To Expect From Federal Reserve, Bank of Japan, Bank Of England This Week</a>
Photo: Courtesy NBY

What's Going On With NovaBay Pharmaceuticals (NBY) Stock?

WIIM

FFIV

F5 shares are trading higher after the company reported better-than-expected Q3 financial results. Additionally, the company raised its FY24 earnings guidance above estimates.

Adjusted EBITDA Of $28 Million To $32 Million.

Guidance

Symbotic Expects Q4 Revenue Of $455M - $475M (Est $516.84M)

TLRY

Tilray Brands shares are trading higher after the company reported better-than-expected Q4 financial results.

CORT

Corcept Therapeutics shares are trading higher after the company reported better than expected Q2 financial results and raised its FY24 revenue guidance above estimates.

AMKR

Amkor Technology shares are trading lower after the company issued roughly inline guidance.

Etsy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETSY#NYSE">ETSY</a>) short percent of float has risen 3.26% since its last report. The company recently reported that it has 14.95 million shares sold short, which is 14.58% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.35 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Etsy Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1722285021_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Etsy has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Etsy's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Etsy's peer group average for short interest as a percentage of float is 10.95%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

ETSY

How Is The Market Feeling About Etsy?

Jacobs Solutions's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/J#NYSE">J</a>) short percent of float has fallen 9.16% since its last report. The company recently reported that it has 1.30 million shares sold short, which is 1.19% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.48 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Jacobs Solutions Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1722285016_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Jacobs Solutions has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Jacobs Solutions's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Jacobs Solutions's peer group average for short interest as a percentage of float is 3.40%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(J) - Analyzing Jacobs Solutions's Short Interest

Pfizer's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) short percent of float has fallen 7.55% since its last report. The company recently reported that it has 55.70 million shares sold short, which is 0.98% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.99 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Pfizer Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1722285011_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Pfizer has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Pfizer's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Pfizer's peer group average for short interest as a percentage of float is 5.39%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(PFE) - Analyzing Pfizer's Short Interest

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/CNPOF">RIV Capital</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNPOF#OTC">CNPOF</a>) shares closed up 48.61% at $0.11</li>
<li><a href="https://www.benzinga.com/quote/CPHRF">Cipher Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CPHRF#OTC">CPHRF</a>) shares closed up 19.97% at $7.45</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed up 17.41% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/BLOZF">Cannabix Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed up 16.31% at $0.40</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed up 10.71% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed up 9.84% at $1.83</li>
<li><a href="https://www.benzinga.com/quote/HERTF">Heritage Cannabis Holding</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HERTF#OTC">HERTF</a>) shares closed up 7.69% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 7.65% at $0.18</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed up 7.30% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Glb Inv</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed up 6.98% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 6.53% at $0.28</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed up 3.73% at $5.99</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed up 3.21% at $0.29</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed up 3.06% at $0.17</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/GRNH">GreenGro Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GRNH#OTC">GRNH</a>) shares closed down 96.55% at $1e-06</li>
<li><a href="https://www.benzinga.com/quote/GBHPF">Global Hemp Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBHPF#OTC">GBHPF</a>) shares closed down 54.25% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 45.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed down 40.48% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed down 23.93% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">Cansortium</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed down 14.25% at $0.12</li>
<li><a href="https://www.benzinga.com/quote/CBWTF">Auxly Cannabis Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) shares closed down 6.97% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed down 6.83% at $0.54</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed down 6.09% at $1.11</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed down 4.55% at $2.31</li>
<li><a href="https://www.benzinga.com/quote/MXC">Mexco Energy</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MXC#AMEX">MXC</a>) shares closed down 3.46% at $10.60</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed down 3.03% at $0.02</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

Markets

Movers

BBRRF

BLOZF

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CNBX

CNPOF

CNTMF

CPHRF

CWBHF

CXXIF

ELLXF

GBHPF

GNLN

GRNH

GRWG

HERTF

ITHUF

KAYS

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

NWVCF

OILFF

SOLCF

YCBD

Cannabis Stock Movers For July 29, 2024

HSCS

HeartSciences Says As Of April 30, 2024, Cash And Cash Equivalents Were ~$5.8M And Shareholders' Equity Was Approximately $7.3M

HLIT

Harmonic Sees Q3 2024 Net Revenue $175M-$190M Vs $133.66M Estimate

ACMR

ACM Research Announces Ultra C Vac-P Flux Cleaning Tool For Fan-Out Panel-Level Packaging; Receives Purchase Order From Major China Semiconductor Manufacturer, Shipped In July

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

SHL Telemedicine Ltd PGIM US Large-Cap Buffer 12 ETF - November

News

Latest news for SHL Telemedicine Ltd PGIM US Large-Cap Buffer 12 ETF - November (BATS:NOVP)